ORLANDO, Fla. — In a substudy of CAT-HF, patients with HF, sleep-disordered breathing and an implantable cardiac device assigned adaptive servo-ventilation plus optimal medical therapy had a reduction ...
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback